Longer Read
‘An exciting time’: a new era in treating migraine
New treatment options and changes to the scheduling of existing medicines are heralding changes to the outlook for patients who experience migraine, writes Megan Haggan “It’s an exciting time in …
Opioids, overdose and naloxone: starting the conversation
Risk factors for overdose are surprisingly common among patients taking prescribed opioids, but how can pharmacists best approach conversations around safety and prevention? Sheshtyn Paola investigates Most people know that …
Ozempic isn’t approved for weight loss in Australia. So how are people accessing it?
Hundreds of thousands of people worldwide are taking drugs like Ozempic to lose weight. But what do we actually know about them? The Conversation’s experts, Andrew Bartlett, Jessica Pace and …
Cardiovascular risks and COVID-19
New research confirms the benefits of vaccination, writes Glen Pyle, Dalhousie University COVID-19 is a respiratory disease. Yet, from the earliest days of the pandemic, the cardiovascular risks associated with …
Regulatory barriers may not be enough to stop CWH, Sigma merger
Sigma Healthcare’s merger with Chemist Warehouse may go ahead despite competition concerns Associate Professor of Finance at RMIT, Angel Zhong, warns Corporate Australia loves a big merger. And amid a growing …
Shaking up the system
How have the recent seismic changes to the community pharmacy landscape affected the way you should view your banner group relationship? We speak to the experts The announcement of the …
Setting your sights on eye health
From dry eyes and myopia to macular degeneration, pharmacists can raise awareness of the importance of eye health KEY POINTS: 13 million Australians have one or more chronic eye condition. …
Supplementing your customer’s knowledge
Pharmacists are the gatekeepers of medicines—including complementary meds. As the industry grows, so too does the need for pharmacists to be informed about the latest trends, evidence and interactions. By …
‘Surprisingly good start’ to vax payment program
With close to half of Australia’s 5,949 Section 90 approved community pharmacies signed up, administrators believe the National Immunisation Program Vaccination in Pharmacy (NIPVIP) is off to a good start, …
The case for importing
Taking expensive medicines or ones unavailable in Australia? Importing may be the answer, write Jacinta Johnson and Kirsten Staff The cost-of-living crisis may be driving some Australians to look for …
The first stop
From managing minor ailments to educating on antibiotics, fever and concussion – pharmacists can make a significant impact on children’s health, says Leanne Philpott Back to school’ means a lot …
Vaccination: lessons from the Covid-19 pandemic
The pandemic changed everything when it comes to vaccination by pharmacists. So where are we at now? By Jala Moushi The role of pharmacists has evolved from traditional medication dispensers …